Your Navigation:PCAR > Abstract
Search pcar
Pharmaceutical Care and Research: 2019; 19(3):238-240
DOI: 10.5428/pcar20190321
Analysis of anti-infective therapy of a patient with intermittent fever for two years
1. LU Hong(a
2. QU Jian(a )
3. LIU Yiping(a )
Welcome to PCAR! You are the number 145 reader of this article!
Please cite this article as:
LU Hong,QU Jian,LIU Yiping,. Analysis of anti-infective therapy of a patient with intermittent fever for two years[J]. Pharmaceutical Care and Research / yao xue fu wu yu yan jiu. 2019; 19(3): 238-240.
1. LIANG Zengwei,XIE Xushuo,HUANG Xiaohan,et al.Etiologies of 224 patients with fever of unknown origin[J].Chin J Infect Control,2015,14(12):814-817.In Chinese with English abstract.
2. Infectious Diseases Specialized Committee,Chinese Medical Education Association.Expert consensus on clinical significance interpretation of infection-related biomarkers [J].Chin J Tuberc Respir Dis,2017,40(4): 243-257.In Chinese.
3. ZHU Meiying,CAO Ehong.Detection and application of procalcitonin-interpretation for Expert consensus on clinical significance interpretation of infection-related biomarkers[J].Shanghai Med Pharm J,2018,39(1):14-18.In Chinese with English abstract.
4. GU Min,BAO Zhengjun,ZENG Xinrong,et al.Serum procalcitonin levels in patients infected by either gram-positive or gram-negative bacteria[J].Chin J Infect Control,2011,10(6): 449-451,448.In Chinese with English abstract.
5. WANG Hongxing,TIAN Hongying,ZHANG Qinghong.Advances in antibacterial activity of meropenem[J].Chin Hosp Pharm J,2010,30(11):963-964.In Chinese.
6. ZHONG Yan,XING Weifan.The fourth generation of cephalosporin-cefoselis sulfate[J].Foreign Med Antibiot,2000,21(2):75-78,90.In Chinese.
7. YUAN Jinyi,LI Guanghui.Cefoselis:a new fourth generation cephalosporin[J].Chin J Infect Chemother,2011,11(4):308-313.In Chinese with English Title.
8. MEI Dan.New carbapenems antibiotics-meropenem[J].Chin Pharm J,1998,33(11):696-698.In Chinese.
9. ZHU Demei,YE Xinyu,GUO Yan,et al.In vitro activities of cefoselis compared to β-lactams and other antibacterial agents against gram-positive and gram-negative clinical isolates[J].Chin J Infect Chemother,2011,11(4):241-255.In Chinese with English abstract.
10. Chimura T,Hirayama T,Morisaki N,et al.Clinical effects of cefoselis (CFSL) on infections in obstetric and gynecologic field and prevention of postoperative infections[J].Jap J Antibiot,2000,53(11):637-641.
《药学服务与研究》杂志社 All Rights Reserved 网站备案号:鲁B2-20061008
·地址:上海市杨浦区长海路168号18号楼东三楼 邮政编码:200433
·联系电话(传真):86-21-65519829, 021-31162330